Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update
14. November 2023 16:05 ET
|
Vivos Therapeutics, Inc
Operating Expenses Decreased 32% Year Over Year and 19% Sequentially as Cost Cutting Measures Take Hold New Strategic Relationships, Including U.S. Nationwide Distribution Agreement with Lincare,...
Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
09. November 2023 16:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for...
Vivos Therapeutics Closes $4 Million Private Placement
02. November 2023 17:00 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for...
Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
31. Oktober 2023 08:00 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for...
Vivos Therapeutics Announces Reverse Stock Split
26. Oktober 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for...
Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare
24. Oktober 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS a leading medical technology company focused on developing innovative treatments...
Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine
11. Oktober 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company") (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for...
Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion
05. Oktober 2023 07:30 ET
|
Vivos Therapeutics, Inc
Vivos Executes Distribution Agreement with Established Dubai-based Sleep Testing Company Subject to Regulatory Approvals, Vivos Could See Revenue From This Collaboration in 2024 LITTLETON,...
Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers
04. Oktober 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development...
New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference
02. Oktober 2023 07:30 ET
|
Vivos Therapeutics, Inc
LITTLETON, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development...